Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2017 06:00 ET | Source: Invivoscribe Technologies Inc.

Invivoscribe Expands Ion PGM(TM) NGS Platform Menu: Releases Additional CE-IVD Clonality Kits with Bioinformatics Software and RUO Kits with MRD Software

SAN DIEGO, CA--(Marketwired - Feb 28, 2017) - Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the...
March 29, 2016 08:00 ET | Source: Invivoscribe Technologies, Inc.

German Supreme Court Upholds and Strengthens Invivoscribe FLT3 Patent Position

SAN DIEGO, CA--(Marketwired - Mar 29, 2016) - In a landmark patent decision that will accelerate approval of new drugs and improve treatment of patients with acute myeloid leukemia (AML), the...
February 10, 2016 08:00 ET | Source: Invivoscribe Technologies, Inc.

Invivoscribe Announces Long-Term Collaboration to Develop Immuno-Oncology Tests With Thermo Fisher Scientific

SAN DIEGO, CA--(Marketwired - Feb 10, 2016) - Invivoscribe® Technologies, Inc., a global company that provides international access to personalized molecular diagnostics, today announces it...
April 28, 2015 08:07 ET | Source: Invivoscribe Technologies, Inc.

Invivoscribe Technologies Announces Companion Diagnostic Agreement

SAN DIEGO, CA--(Marketwired - Apr 28, 2015) - Invivoscribe® Technologies, Inc., a company with international experience commercializing in vitro diagnostic tests and developing companion...
April 21, 2015 08:07 ET | Source: Invivoscribe Technologies, Inc.

Invivoscribe(R) Launches Four CE-Marked NGS-Based LymphoTrack(R) Dx Assays

SAN DIEGO, CA--(Marketwired - Apr 21, 2015) - Invivoscribe Technologies, Inc. (IVS) announced today the commercial release of four CE-marked LymphoTrack® Dx next-generation sequencing (NGS)...
March 17, 2015 06:00 ET | Source: Invivoscribe Technologies, Inc.

Genection Announces Launch of MyAML(TM), a Next Generation Sequencing (NGS) Assay for Acute Myeloid Leukemia

SAN DIEGO, CA--(Marketwired - Mar 17, 2015) - Genection™, Inc., a subsidiary of Invivoscribe Technologies®, Inc., announced today that it has launched MyAML™, a CLIA validated next...
December 05, 2012 08:38 ET | Source: Invivoscribe Technologies, Inc.

Takara Bio Grants Patent License to Invivoscribe Technologies for FLT3-ITD Testing in Japan

SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - Invivoscribe Technologies, Inc. (San Diego, California) announced today that it has entered into an agreement with Takara Bio, Inc. (Otsu, Shiga, Japan)...